<PAGE> 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
CAREADVANTAGE, INC.
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
(Title of Class of Securities)
14166N209
(CUSIP Number)
Robert J. Pures
Senior Vice President - Administration, Chief
Financial Officer and Treasurer Blue Cross
and Blue Shield of New Jersey, Inc.
Three Penn Plaza East
Newark, New Jersey 07105-2200
(201) 466-8500
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
June 13, 1997
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box. / /
Check the following box if a fee is being paid with this statement. / /
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom copies
are to be sent.
(Continued on following pages)
(Page 1 of 13 Pages)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act") or otherwise subject to the
liabilities of that section of the Exchange Act shall be subject to all other
provisions of the Exchange Act (however, see the Notes).
<PAGE> 2
Page 2 of 13 Pages
SCHEDULE 13D
CUSIP No. 14166N209
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Blue Cross and Blue Shield of New Jersey, Inc. - Fed.
I.D. # 22-0999690
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) /X/
3. SEC USE ONLY
4. SOURCE OF FUNDS
AF
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(D) OR 2(E) / /
6. CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
NUMBER OF 7. SOLE VOTING POWER
SHARES
BENEFICIALLY 37,617,420
OWNED BY EACH
REPORTING
PERSON WITH
8. SHARED VOTING POWER
75,401,507 See Item 5(a) and (b).
9. SOLE DISPOSITIVE POWER
37,617,420
10. SHARED DISPOSITIVE POWER
75,401,507 See Item 5(a) and (b).
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
37,617,420 See Item 5(a).
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES /X/
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
50.6% See Item 5(a).
14. TYPE OF REPORTING PERSON
CO
<PAGE> 3
Page 3 of 13 Pages
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
Blue Cross and Blue Shield of New Jersey, Inc. ("BCBSNJ") and CW
Ventures II, L.P. ("CW") have entered into an Option Agreement (the "Option
Agreement") dated as of June 13, 1997. Under the Option Agreement, CW granted
BCBSNJ an option (the "Option") to purchase 10,031,238 shares of common stock,
$.001 par value (the "Common Stock") of CareAdvantage, Inc. (the "Company"),
such shares (the "Option Shares") representing 12% of the Common Stock on a
fully-diluted basis, at a purchase price per share of $0.38 (the "Exercise
Price").
The Option is subject to certain conditions to exercisability:
(i) the Option will become exercisable to purchase 50% of the Option
Shares only if (x) certain payments to the Company or its subsidiaries under the
First Amendment and Restatement of Services Agreement dated as of June 13, 1997
(the "Services Agreement") by and among Contemporary HealthCare Management, Inc.
("CHCM"), BCBSNJ, CareAdvantage Health Systems, Inc. ("CAHS") and the Company
equal or exceed specified levels during the Company's current fiscal year and
(y) certain payments to the Company under the letter agreement dated as of April
1, 1997 by and among Allied Health Group, Inc. ("Allied"), Medigroup of New
Jersey, Inc. ("HMO Blue") and the Company, and related agreements (collectively,
the "Allied Agreement"), equal or exceed specified levels during the Company's
current fiscal year; and
(ii) the Option will become exercisable to purchase some or all of the
remaining 50% of the Option Shares only if payments to the Company under the
Allied Agreement and related agreements equal or exceed specified levels during
the period from March 1, 1997 through February 28, 2000.
Each of CHCM and CAHS is a wholly owned subsidiary of the Company. HMO Blue is a
wholly owned subsidiary of BCBSNJ.
Exercisability of the Option may be accelerated under certain
circumstances. If on or prior to February 28, 2000 the Company consummates any
sale, lease, exchange or other transfer (in one transaction or a series of
related transactions) of all or substantially all of its assets or capital
stock, for consideration of not less than $0.60 per share of Common Stock on a
fully-diluted basis, then the Option will, unless previously terminated, become
exercisable immediately prior to the referenced transaction. In addition, on any
date on or after December 13, 1998, CW may, at its sole option, notify BCBSNJ
that all, but not less than all, of the Option not then exercisable will
immediately become exercisable, provided that the fair market value (as defined)
on the date of such notice is not less than 150% of the Exercise Price.
The Option Agreement contains certain representations and warranties by
each of CW and BCBSNJ, including representations by BCBSNJ regarding the
Services Agreement, the Allied Agreement and certain other agreements entered
into prior to or in connection with the Option Agreement. A copy of the Option
Agreement is attached as Exhibit 5 to this Schedule 13D and incorporated herein
by reference. Copies of the Services Agreement, the Allied Agreement and such
other agreements are incorporated herein by reference to the Company's Quarterly
Report on Form 10-QSB for the Quarterly Period ended April 30, 1997 (the "Form
10-QSB").
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
5. Copy of the Option Agreement dated as of June 13, 1997 by and
among CW and BCBSNJ.
6. Copy of the First Amendment and Restatement of Services
Agreement dated as of June 13, 1997 by and among CHCM, BCBSNJ,
CAHS and the Company (incorporated herein by reference to the
Form 10-QSB).
7. Copy of the letter agreement dated as of April 1, 1997 by and
among Allied, HMO Blue and the Company, and related agreements
(incorporated herein by reference to the Form 10-QSB).
8. Copy of the Credit Agreement dated as of June 13, 1997 by and
among Summit Bank, the Company and BCBSNJ, and related
agreements (incorporated herein by reference to the Form
10-QSB).
<PAGE> 4
Page 4 of 13 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
June 26, 1997
----------------------------
(Date)
BLUE CROSS AND BLUE SHIELD OF NEW
JERSEY, INC.
/s/ Robert J. Pures
------------------------------------------
Name: Robert J. Pures
Title: Senior Vice President - Administration,
Chief Financial Officer & Treasurer
<PAGE> 5
Page 5 of 13 Pages
APPENDIX A
INFORMATION REQUIRED BY ITEM 2 OF
THE SPECIAL INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13D
The following information is based on the knowledge of Blue
Cross and Blue Shield of New Jersey, Inc. ("BCBSNJ"), the entity filing this
Schedule 13D:
With Respect to the Directors and Executive Officers of
BCBSNJ:
32. Mr. Francis X. Fee
(a) Mr. Fee is a citizen of the United States of
America.
(b) Mr. Fee's business address is Three Penn
Plaza East, Newark, New Jersey 07105-2200.
(c) Mr. Fee is Vice President - Corporate and
Major Accounts of BCBSNJ.
(d) During the last five years, Mr. Fee has not
been convicted in a criminal proceeding
(excluding traffic violations or similar
misdemeanors).
(e) During the last five years, Mr. Fee has not
been a party to a civil proceeding of a
judicial or administrative body of competent
jurisdiction as a result of which proceeding
he was or is subject to a judgment, decree
or final order enjoining future violations
of, or prohibiting or mandating activities
subject to, federal or state securities laws
or finding any violation with respect to
such laws.
<PAGE> 6
Page 6 of 13 Pages
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT PAGE
<S> <C>
5 Copy of the Option Agreement dated as of June 13, 1997 by among 7
CW Ventures II, L.P. and Blue Cross and Blue Shield of New Jersey,
Inc. ("BCBSNJ").
6 Copy of the First Amendment and Restatement of Services Agreement (a)
dated as of June 13, 1997 by and among Contemporary HealthCare
Management, Inc., BCBSNJ, CareAdvantage Health Systems, Inc.
and CareAdvantage, Inc. (the "Company").
7 Copy of the letter agreement dated as of April 1, 1997 by and among (b)
Allied Health Group, Inc., Medigroup of New Jersey, Inc. and the
Company, and related agreements.
8 Copy of the Credit Agreement dated as of June 13, 1997 by and among (c)
Summit Bank, the Company and BCBSNJ, and related agreements.
</TABLE>
- -----------------------------
(a) Incorporated by reference to Exhibit 10(b) to the Company's
Quarterly Report on Form 10-QSB for the Quarterly Period ended
April 30, 1997 (the "Form 10-QSB").
(b) Incorporated by reference to Exhibit 10(e) to the Form 10-QSB.
(c) Incorporated by reference to Exhibits 10(f) and 10(f)(1)
through 10(f)(4) to the Form 10-QSB.
<PAGE> 1
Page 7 of 13 Pages
OPTION AGREEMENT
AGREEMENT made as of the 13th day of June, 1997 (the
"Effective Date") by and among CW Ventures II, L.P., a New York limited
partnership (the "Grantor") and Blue Cross and Blue Shield of New Jersey, Inc.,
a New Jersey health service corporation (the "Optionee").
W I T N E S S E T H
WHEREAS, the Grantor desires to grant to the Optionee and the
Optionee desires to accept an option to purchase certain shares of common stock
("Common Stock"), $.001 par value, of CareAdvantage, Inc., a Delaware
corporation (the "Company"), that are owned by the Grantor upon the terms and
conditions set forth in this agreement.
NOW, THEREFORE, the parties hereto agree as follows:
1. Grant. Upon the terms and subject to the conditions contained herein, the
Grantor hereby grants to the Optionee an option (the "Option") to purchase
10,031,238 shares of Common Stock (the "Option Shares") (such Option Shares
representing twelve percent (12%) of the Common Stock on a fully-diluted basis),
at a purchase price per share of $0.38 (the "Exercise Price").
2. Exercise.
(a) The Option may be exercised in whole or in part upon the
terms and subject to the conditions contained herein by delivering to the
Grantor, with copies to the Secretary of the Company, (i) a written notice
specifying the number of shares to be purchased, (ii) a letter in the form of
Exhibit A attached hereto and (iii) against receipt of a share certificate
representing the shares being purchased, payment in full of the Exercise Price.
The Exercise Price shall be payable in cash by bank or certified check or by
wire transfer to an account specified by the Grantor. Unless sooner terminated,
the Option will expire, if and to the extent not exercised, (x) with respect to
the Group A Option Shares (as hereinafter defined), at the close of business on
October 31, 2000 (the "Group A Expiration Date"); and (y) with respect to the
Group B Option Shares (as hereinafter defined), at the close of business on the
first anniversary of the Target Date (as hereinafter defined) (the "Group B
Expiration Date").
(b) Notwithstanding any provisions herein to the contrary, if
the fair market value (as hereinafter defined) of one share of Common Stock is
greater than the Exercise Price as of the Date of Calculation (as hereinafter
defined), in lieu of exercising the Option for cash, the Optionee may elect to
pay the Exercise Price by surrendering for cancellation a portion of the Option,
in which event the Grantor shall transfer to the Optionee a number of shares of
Common Stock computed using the following formula:
Y (A-B)
X = ----------------
B
Where X = the number of shares of Common Stock to be issued to
the Optionee
Y = the number of shares of Common Stock purchasable
under the portion of the Option being surrendered for
cancellation (at the Date of Calculation)
A = the fair market value of one share of the Common
Stock (at the Date of Calculation)
B = Exercise Price (as adjusted to the Date of
Calculation)
For purposes of the above calculation, (i) "fair market value" of one share of
Common Stock shall be the average for the thirty (30) consecutive business days
immediately prior to the Date of Calculation of the closing bid and asked prices
of the Common Stock quoted in the over-the-counter market or the last reported
sale prices of the Common Stock or the closing prices quoted on the Nasdaq
National Market or on any exchange on which the Common Stock is listed,
whichever
<PAGE> 2
Page 8 of 13 Pages
is applicable, or, if no such quotation exists for the Common Stock, the fair
market value of one share of Common Stock shall be determined by an investment
banking or valuation firm acceptable to the Grantor and the Optionee and (ii)
"Date of Calculation" with respect to any exercise in whole or in part of the
Option shall be the date which is five (5) business days prior to the issuance
of a share certificate and the payment of the Exercise Price in connection with
such exercise, as contemplated by clause (iii) of Section 2(a) hereof.
3. Conditions to the Exercisability of the Option.
(a) The Option will become exercisable to purchase 50% of the
Option Shares ("Group A Option Shares") if (i) payments by the Optionee to the
Company or its subsidiaries under the Services Agreement (as hereinafter
defined) during the Company's fiscal year ending October 31, 1997 (the "1997
Target Indemnity Payments") equal or exceed $10 million and (ii) payments by HMO
Blue to the Company of the aggregate Fees (as such term is defined in the Side
Agreement (as hereinafter defined)) during the Company's fiscal year ending
October 31, 1997 (the "1997 Target HMO Blue Payments") equal or exceed $4.0
million.
(b) The Option will become exercisable to purchase the
percentage indicated under column (a) below of the Option Shares ("Group B
Option Shares") if payments by HMO Blue to the Company of the aggregate Fees
under the Side Agreement (the "2000 Target HMO Blue Payments") during the period
from March 1, 1997 until and including February 28, 2000 (the "Target Date") are
equal to or exceed the amounts set forth opposite such percentage in column (b)
below:
<TABLE>
<CAPTION>
Percentage of Option Payments Under
Exercisable (a) Side Agreement (b)
------------------ ------------------
<S> <C>
30% At least $22.5 million
35% At least $26.25 million
40% At least $30 million
45% At least $33.75 million
50% At least $37.5 million
</TABLE>
(c) Notwithstanding any provisions herein to the contrary, in
the event that the HMO Blue Contract (as hereinafter defined) or the Side
Agreement is terminated at any time after October 31, 1997 by HMO Blue as a
result of a material breach thereof by the Company or Allied, or by Allied
without cause, then (i) each of the amounts set forth in column (b) above shall
be adjusted by multiplying such amount by a fraction, the numerator of which is
the number of months between March 1, 1997 and the date of termination with
respect to which payments have been made by HMO Blue to the Company pursuant to
the Side Agreement and the denominator of which is thirty six (36) and (ii) the
Target Date shall be deemed to be the date of such termination.
(d) As soon as practicable and in no event later than January
31, 1998, the Company shall deliver to the Grantor and the Optionee a
calculation of the 1997 Target Indemnity Payments (the "1997 Indemnity
Calculation") and a calculation of the 1997 Target HMO Blue Payments (the "1997
Blue Calculation") prepared by the Company's independent accountants.
(e) As soon as practicable and in no event later than 45 days
following the Target Date, the Company shall deliver to the Grantor and the
Optionee a calculation of the 2000 Target HMO Blue Payments (the "2000 Blue
Calculation") prepared by the Company's independent accountants.
(f) Within 30 days after receipt of each of the 1997 Indemnity
Calculation, the 1997 Blue Calculation and the 2000 Blue Calculation, the
Grantor and the Optionee shall inform each other and the Company in writing
either that the 1997 Blue Calculation, the 1997 Indemnity Calculation and the
2000 Blue Calculation, as the case may be, is acceptable or object to the
calculation in writing, setting forth a specific description of such party's
objections (it being agreed that the failure of either such party to deliver
such written notice to the other parties within such 30-day period shall be
deemed acceptance by such party). If either the Grantor or the Optionee objects
as provided above and if
-8-
<PAGE> 3
Page 9 of 13 Pages
the other party does not agree with the objecting party's objections, and such
objections are not resolved on a mutually agreeable basis within 30 days after
the objecting party's receipt of the other party's notice of disagreement with
the objecting party's objections, any such disagreement shall be promptly
submitted to a mutually acceptable accounting firm (the "Unaffiliated Firm").
The Unaffiliated Firm shall resolve within thirty (30) days after said
Unaffiliated Firm's engagement by the parties the differences regarding the 1997
Blue Calculation, the 1997 Indemnity Calculation or the 2000 Blue Calculation,
as the case may be, in accordance with generally accepted accounting principles
consistently applied and this Agreement. The decision of such Unaffiliated Firm
shall be final and binding upon, and its fees, costs and expenses shall be
shared equally by the Grantor and the Optionee. Each party hereto shall bear the
fees, costs and expenses of its own accountants. Upon resolution of any such
dispute, the determination of the 1997 Blue Calculation, the 1997 Indemnity
Calculation or the 2000 Blue Calculation, as the case may be, shall be deemed to
be final.
4. Representations and Warranties of the Grantor. The Grantor
represents and warrants to, and agrees with, the Optionee that:
(a) the Grantor is a limited partnership that is duly
organized, validly existing and in good standing under the laws of the
jurisdiction of its organization, and the Grantor's general partner, on behalf
of the Grantor, has taken all action necessary for the execution and delivery of
this Agreement;
(b) the Grantor has full power and authority to execute and
deliver this Agreement and to sell, assign, transfer and deliver to the Optionee
the shares of Common Stock to be sold by the Grantor upon exercise of the Option
upon the terms and subject to the terms contained herein, and this Agreement has
been duly executed and delivered by the Grantor and constitutes the valid and
binding agreement of the Grantor enforceable in accordance with its terms;
(c) the Grantor is the lawful owner of the Option Shares free
and clear of all security interests, liens, encumbrances, equities, claims or
other defects, and upon sale and delivery of, and payment for, such shares as
provided herein, the Grantor will convey to the Optionee good and marketable
title to such shares, free and clear of any security interests, liens,
encumbrances, equities, claims or other defects; and
(d) the execution and delivery of this Agreement and the
consummation of the transactions herein contemplated do not (i) require the
consent, approval, authorization, registration or qualification of or with any
governmental authority on the part of the Grantor or (ii) conflict with or
result in a breach or violation of any of the terms and provisions of, or
constitute a default under, the Grantor's limited partnership agreement or any
indenture, mortgage, deed of trust, lease or other agreement or instrument to
which the Grantor is a party or by which the Grantor or any of the Grantor's
properties are bound or any statute or any judgment, decree, order, rule or
regulation of any court or other governmental authority or any arbitrator
applicable to the Grantor.
5. Representations and Warranties of the Optionee.
The Optionee hereby represents and warrants to, and agrees
with, the Grantor that:
(a) the Optionee is a corporation that is duly organized,
validly existing and in good standing under the laws of the jurisdiction of its
organization, and has taken all action necessary for the execution and delivery
of this Agreement;
(b) the Optionee has full power and authority to execute and
deliver this Agreement, and this Agreement has been duly executed and delivered
by the Optionee and constitutes the valid and binding agreement of the Optionee
enforceable in accordance with its terms;
(c) the execution and delivery of this Agreement and the
consummation of the transactions herein contemplated do not (i) require the
consent, approval, authorization, registration or qualification of or with any
governmental authority on the part of the Optionee, or (ii) conflict with or
result in a breach or violation of any of the terms and provisions of, or
constitute a default under, the Optionee's certificate of incorporation or
by-laws or any indenture, mortgage, deed of trust, lease or other agreement or
instrument to which the Optionee is a party or by which the Optionee or any of
the Optionee's properties are bound or any statute or any judgment, decree,
order, rule or regulation of any court or other governmental authority or any
arbitrator applicable to the Optionee;
-9-
<PAGE> 4
Page 10 of 13 Pages
(d) the Optionee will not offer, sell, transfer or otherwise
dispose of the Common Stock issued upon exercise of the Option unless (i) an
effective registration statement under the Securities Act of 1933, as amended
(the "Securities Act"), covers the disposition of such securities or (ii) the
Optionee has delivered to the Company an opinion of counsel, reasonably
satisfactory to the Company, that such offer, sale, transfer or other
disposition will not require registration of such securities under the
Securities Act;
(e) the Optionee understands that the shares of Common Stock
issued upon exercise of the Option must be held indefinitely unless they are
subsequently registered under the Securities Act or an exemption from such
registration is available. The Optionee has been advised or is aware of the
provisions of Rule 144, which permits limited resale of shares subject to the
satisfaction of certain conditions, and understand that such Rule is not now,
and may not become, available for resale of the shares of Common Stock issued
upon exercise of the Option; and
(f) the Optionee has knowledge and experience in financial and
business matters and is capable of evaluating the merits and risks of an
investment in the Common Stock issuable upon exercise of the Option and of
making an informed decision. The Optionee recognizes that the purchase of the
Common Stock issuable upon exercise of the Option involves a substantial degree
of risk and has the financial ability to bear the economic risk of this
investment. The Optionee has determined that the Common Stock issuable upon
exercise of the Option is a suitable investment and at this time he can bear a
complete loss of its investment; and
(g) prior to or in connection with the execution and delivery
of this Agreement, each of the following documents has been duly executed and
delivered by each of the respective parties thereto:
(i)(x) the First Amendment and Restatement of Services
Agreement, dated as of June 13, 1997 (the "Services Agreement"), by and
among Contemporary HealthCare Management, Inc., a New Jersey
corporation ("CHCM"), the Optionee, the Company and Care Advantage
Health Systems, Inc., a Delaware corporation, in the form of Exhibit B
hereto, and (y) the related note contemplated by Section 4.3 of the
Services Agreement, payable by CHCM to the order of the Optionee, in
the form of Exhibit C hereto.
(ii)(w) the Administrative Service Agreement, dated as of
January 2, 1997 (the "HMO Blue Contract"), by and between Allied Health
Group, Inc., a Florida corporation ("Allied"), and Medigroup of New
Jersey, Inc., a New Jersey corporation and wholly owned subsidiary of
the Optionee, doing business as HMO Blue ("HMO Blue"), in the form of
Exhibit D hereto, (x) the related letter agreement, dated as of March
1, 1997 (the "Side Agreement"), among the Company, Allied and HMO Blue,
in the form of Exhibit E hereto, (y) the related letter agreement dated
as of March 1, 1997 between the Company and HMO Blue, in the form of
Exhibit F hereto, and (z) the related letter agreement dated as of June
13, 1997 between the Company and HMO Blue, in the form of Exhibit G
hereto; and
(iii)(x) the Credit Agreement, dated as of June 13, 1997, by and
among the Company, the Optionee and Summit Bank, a banking institution
of the State of New Jersey (the "Bank"), in the form of Exhibit H
hereto, and (y) the related Guaranty Agreement, by the Optionee in
favor of the Bank, in the form of Exhibit I hereto.
6. Intentionally Omitted.
7. Other Agreements. The Grantor hereby agrees not to offer to
sell, sell, contract to sell, transfer, pledge or otherwise dispose of any
Option Shares, other than pursuant to this Agreement, from the date hereof until
the day following the last Expiration Date.
8. Acceleration of Exercisability.
(a) If on or prior to the Target Date there shall be
consummated any sale, lease, exchange or other transfer (in one transaction or a
series of related transactions) of all, or substantially all, of the assets or
capital stock of the Company, for consideration consisting of cash, securities
or other property representing consideration of not less than $0.60 per share of
Common Stock on a fully-diluted basis (appropriately adjusted for any stock
split, stock dividend or similar transaction which increases or decreases the
number of outstanding shares of Common Stock), then the Option shall, unless
sooner terminated under the terms hereof, become exercisable immediately prior
to the closing of such transaction.
-10-
<PAGE> 5
Page 11 of 13 Pages
(b) On any date (an "Acceleration Date") on or after
the 18 month anniversary of the Effective Date, the Grantor may, at its sole
option, declare and give written notice to the Optionee stating that all, but
not less than all, of the Option not then exercisable shall immediately become
exercisable; provided, that the fair market value (as defined in Section 2
hereof) on such date of one share of Common Stock is not less than 150% of the
Exercise Price.
(c) In the event that the exercisability of all or
any portion of the Option is accelerated under this Section 9, the Expiration
Date with respect to the portion of the Option so accelerated shall be the close
of business on the 10th business day following the relevant Acceleration Date.
9. Capital Changes.
(a) In the event of any stock split, stock dividend
or similar transaction which increases or decreases the number of outstanding
shares of Common Stock, appropriate adjustment shall be made by the Grantor to
the number of Option Shares and Exercise Price. In the case of a merger,
consolidation or similar transaction which results in a replacement of the
Company's Common Stock with stock of another corporation, the Grantor will
replace the Option granted hereunder with comparable Options to purchase the
stock of such other corporation, or will provide for acceleration of the
exercisability of the Option.
(b) In the event of any adjustment in the number of
Option Shares pursuant to the provisions hereof, any fractional shares resulting
from such adjustment will be disregarded and each such Option will cover only
the number of full shares resulting from the adjustment.
10. Rights as Stockholder. No shares of Common Stock shall be
sold or delivered hereunder until full payment for such shares has been made.
The Optionee shall have no rights as a stockholder with respect to any shares
covered by the Option until a stock certificate for such shares is issued to the
Optionee by the Company upon cancellation of the stock certificates representing
the shares being sold by the Grantor. Except as otherwise provided herein, no
adjustment shall be made for dividends or distributions of other rights for
which the record date is prior to the date such stock certificate is issued.
11. Restrictive Legends. The Optionee understands and agrees
that the certificates evidencing the Common Stock issued upon exercise of the
Option will bear the following legend (or a substantially similar legend):
"THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER ANY
STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED,
SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF WITHOUT SUCH
REGISTRATION OR THE DELIVERY TO THE COMPANY OF AN OPINION OF
COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH
DISPOSITION WILL NOT REQUIRE REGISTRATION OF SUCH SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED."
12. Notices. Any and all notices, requests, demands and other
communications provided for by this Agreement shall be in writing and shall be
sent by prepaid telex or facsimile or sent postage prepaid by certified mail
(return receipt requested) or reputable courier service and shall be deemed
given when so delivered by hand, telex or facsimile, or if mailed, five days
after mailing (two business days in the case of courier service) to the parties
as follows: to the Grantor, to 1041 Third Avenue, New York, New York 10021, and
to the Optionee at its last known address on the books of the Company, or to
such other address as either party may specify by notice to the other.
13. Entire Agreement. This Agreement constitutes the entire
agreement between the parties relating to the subject matter thereof and
supersedes all prior communications, agreements and understandings, written or
oral, with respect to the terms and conditions of such subject matter.
14. Amendment. This Agreement may be amended or modified only
by a written instrument signed by the Grantor and the Optionee.
-11-
<PAGE> 6
Page 12 of 13 Pages
15. Headings. The headings and captions in this Agreement are
for convenience only and in no way define or describe the scope or content of
any provision of this Agreement.
16. Counterparts. This Agreement may be executed in two or
more counterparts, each of which shall be an original and all of which together
shall constitute one and the same instrument.
IN WITNESS WHEREOF, this Agreement has been executed as of the
date first above written.
CW VENTURES II, L.P.
By: CW PARTNERS III, L.P.,
its general partner
By: /s/ Barry Weinberg
---------------------------------
Name: Barry Weinberg
Title: General Partner
BLUE CROSS AND BLUE SHIELD
OF NEW JERSEY, INC.
By: /s/ Robert J Pures
---------------------------------
Name: Robert J. Pures
Title: SVP - Administration,
Chief Financial Officer
and Treasurer
Acknowledged and agreed to with respect to Sections 3, 10 and 11:
CAREADVANTAGE, INC.
By: /s/ Richard W. Freeman, M.D.
------------------------------------
Name: Richard W. Freeman, M.D.
Title: Senior Vice President
-12-
<PAGE> 7
Page 13 of 13 Pages
EXHIBIT A
To: CW Ventures II, L.P.
[Date]
Dear Sirs:
In connection with the exercise by the undersigned, Blue Cross
and Blue Shield of New Jersey, Inc., of an option to purchase certain shares
(the "Shares") of common stock, par value $.001 per share (the "Common Stock"),
of CareAdvantage, Inc., a Delaware corporation (the "Company"), owned by CW
Ventures II, L.P. ("CW") the undersigned hereby represents, warrants and agrees
as of the date hereof that:
(i) It will not offer, sell, transfer or otherwise dispose of the Shares unless
(i) an effective registration statement under the Securities Act of 1933, as
amended (the "Securities Act"), covers the disposition of such securities or
(ii) it has delivered to CW an opinion of counsel, reasonably satisfactory to
CW, that such offer, sale, transfer or other disposition will not require
registration of such securities under the Securities Act.
(ii) It understands that the shares of Common Stock
must be held indefinitely unless they are subsequently registered under the
Securities Act or an exemption from such registration is available. It has been
advised or is aware of the provisions of Rule 144, which permits limited resale
of shares subject to the satisfaction of certain conditions, and understand that
such Rule is not now, and may not become, available for resale of the shares of
Common Stock.
(iii) It is familiar with the Company's business,
management and financial affairs. It has knowledge and experience in financing
and business matters and is capable of evaluating the merits and risks of an
investment in the Common Stock and of making an informed decision. It recognizes
that the purchase of the Common Stock involves a substantial degree of risk and
has the financial ability to bear the economic risk of this investment. It has
determined that the Common Stock is a suitable investment and at this time he
can bear a complete loss of its investment.
Very truly yours,
BLUE CROSS AND BLUE SHIELD
OF NEW JERSEY, INC.
---------------------------------
Name:
Title:
-13-
